American Journal of Kidney Diseases
Volume 45, Issue 1 , Pages 127-135, January 2005

Improvements in dialysis patient mortality are associated with improvements in urea reduction ratio and hematocrit, 1999 to 2002

  • Robert A. Wolfe, PhD

      Affiliations

    • Department of Biostatistics, University of Michigan, Ann Arbor, MI USA.
    • Corresponding Author InformationAddress reprint requests to Robert A. Wolfe, PhD, University of Michigan, KECC, 315 W Huron, Ste 240, Ann Arbor, MI 48103.
  • ,
  • Tempie E. Hulbert-Shearon, MS

      Affiliations

    • Department of Biostatistics, University of Michigan, Ann Arbor, MI USA.
  • ,
  • Valarie B. Ashby, MA

      Affiliations

    • Department of Biostatistics, University of Michigan, Ann Arbor, MI USA.
  • ,
  • Sangeetha Mahadevan, MS

      Affiliations

    • Department of Biostatistics, University of Michigan, Ann Arbor, MI USA.
  • ,
  • Friedrich K. Port, MD

      Affiliations

    • University Renal Research and Education Association, Ann Arbor, MI.

Received 5 March 2004; accepted 21 September 2004. published online 29 November 2004.

Background: Benefits in terms of reductions in mortality corresponding to improvements in Kidney Disease Outcomes Quality Initiative (K/DOQI) compliance for adequacy of dialysis dose and anemia control have not been documented in the literature. We studied changes in achieving K/DOQI guidelines at the facility level to determine whether those changes are associated with corresponding changes in mortality. Methods: Adjusted mortality and fractions of patients achieving K/DOQI guidelines for urea reduction ratios (URRs; ≥65%) and hematocrit levels (≥33%) were computed for 2,858 dialysis facilities from 1999 to 2002 using national data for patients with end-stage renal disease. Linear and Poisson regression were used to study the relationship between K/DOQI compliance and mortality and between changes in compliance and changes in mortality. Results: In 2002, facilities in the lowest quintile of K/DOQI compliance for URR and hematocrit guidelines had 22% and 14% greater mortality rates (P < 0.0001) than facilities in the highest quintile, respectively. A 10-percentage point increase in fraction of patients with a URR of 65% or greater was associated with a 2.2% decrease in mortality (P = 0.0006), and a 10-percentage point increase in percentage of patients with a hematocrit of 33% or greater was associated with a 1.5% decrease in mortality (P = 0.003). Facilities in the highest tertiles of improvement for URR and hematocrit had a change in mortality rates that was 15% better than those observed for facilities in the lowest tertiles (P < 0.0001). Conclusion: Both current practice and changes in practices with regard to achieving anemia and dialysis-dose guidelines are associated significantly with mortality outcomes at the dialysis-facility level.

Index words:  End-stage renal disease (ESRD) , quality improvement , dose of dialysis , anemia management , standardized mortality ratio (SMR) , hemodialysis (HD) survival

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This study was supported through a grant from the Centers for Medicare and Medicaid Services (CMS contract no. 500-01-0056).

PII: S0272-6386(04)01410-6

doi:10.1053/j.ajkd.2004.09.023

American Journal of Kidney Diseases
Volume 45, Issue 1 , Pages 127-135, January 2005